This page provides manuals, user guides, handbooks, specifications, and maintenance instructions for Health. View online or download for free. Showing page 11.
The “Jin Zi Wei” Anyuan 2M-1 RMB financial product is a保本浮动收益型理财产品, suitable for personal customers who have been assessed by the Taian Bank personal customer investment risk tolerance assessment system as having a steady, balanced, growth or aggressive investment experience and no investment experience.
The present invention relates to a PCR detection kit for African swine fever virus, characterized in that the kit comprises: primers, Ex Taq buffer, Ex Taq Hot-start DNA polymerase, MgCl2, dNTP, wherein the primer sequence is: Prime r:F 5'- TAGAGGACGATACGATGGT-3', R 5'-CGAATGGCTACGGATGAA-3.
The Shenzhen Medical Consumables Sunshine Trading and Regulatory Platform Basic Library Operation Manual (Production Enterprises) introduces how to use the platform.
This document specifies the particular requirements for the basic safety and essential performance of functional near-infrared spectroscopy (NIRS) equipment.
The 2020 Taiwan Acute Kidney Injury Treatment Consensus Conference and Workshop aims to explore the latest topics and treatment方針s for acute kidney disease, and to provide new treatment方針s for future acute kidney injury, improving the treatment prognosis of AKI patients.
CCB Trust “Chengyi”定增主题固收类封闭式产品2020年第2期 is a non-guaranteed floating-rate financial product that does not guarantee principal and income. Performance benchmarks and other statements are not equivalent to actual returns. Clients should be fully aware of investment risks and invest cautiously.
This is a financial product disclosure document. Past performance of financial products does not represent their future performance and does not equal the actual return of financial products. Investment is risky.
浙商银行“永乐 2 号”人民币理财产品 is a non-保本浮动收益型产品, with不定期的开放i天型理财子单元认购及按理财周期兑付, 每个理财子单元有固定的理财周期; 每个理财周期结束时, 分配理财本金及收益(如有, 下同); i 代表理财子单元的理财周期天数, 每个理财子单元的基本要素通过《要素表》确定.
The “Chang Le Bao Ying 3” RMB wealth management product is a non-guaranteed floating-rate wealth management product. The product's expected annualized yield is based on the current open subscription factor table, and the wealth management period is from September 2, 2015 to September 7, 2022.
The CMB Fortune Morning Gold (Multi-Active) Wealth Management Plan is a low-risk investment product, but your principal may still suffer significant losses due to market fluctuations. You should be fully aware of the investment risks and invest cautiously.
The MEGAscript® RNAi Kit is an in vitro transcription kit for producing double-stranded RNA (dsRNA) that can be used in RNA interference (RNAi) studies. The kit contains all necessary reagents, including T7 RNA polymerase, nucleoside triphosphates (NTPs), buffers, and primers.
The MCC Clinical Calculator enables Hospitals to model the potential clinical & operational benefits which may be realized through the use of MCC. The tool further enables scenario-modelling to look at the implications of different deployment options and strategies throughout the different levels of e-health maturity so that the full spectrum can be analysed.
